Literature DB >> 22465051

Creatine metabolism and psychiatric disorders: Does creatine supplementation have therapeutic value?

Patricia J Allen1.   

Abstract

Athletes, body builders, and military personnel use dietary creatine as an ergogenic aid to boost physical performance in sports involving short bursts of high-intensity muscle activity. Lesser known is the essential role creatine, a natural regulator of energy homeostasis, plays in brain function and development. Creatine supplementation has shown promise as a safe, effective, and tolerable adjunct to medication for the treatment of brain-related disorders linked with dysfunctional energy metabolism, such as Huntington's Disease and Parkinson's Disease. Impairments in creatine metabolism have also been implicated in the pathogenesis of psychiatric disorders, leaving clinicians, researchers and patients alike wondering if dietary creatine has therapeutic value for treating mental illness. The present review summarizes the neurobiology of the creatine-phosphocreatine circuit and its relation to psychological stress, schizophrenia, mood and anxiety disorders. While present knowledge of the role of creatine in cognitive and emotional processing is in its infancy, further research on this endogenous metabolite has the potential to advance our understanding of the biological bases of psychopathology and improve current therapeutic strategies.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22465051      PMCID: PMC3340488          DOI: 10.1016/j.neubiorev.2012.03.005

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  249 in total

Review 1.  A neurotrophic model for stress-related mood disorders.

Authors:  Ronald S Duman; Lisa M Monteggia
Journal:  Biol Psychiatry       Date:  2006-04-21       Impact factor: 13.382

2.  Administration of memantine and imipramine alters mitochondrial respiratory chain and creatine kinase activities in rat brain.

Authors:  Gislaine Z Réus; Roberto B Stringari; Gislaine T Rezin; Daiane B Fraga; Juliana F Daufenbach; Giselli Scaini; Joana Benedet; Natália Rochi; Emílio L Streck; João Quevedo
Journal:  J Neural Transm (Vienna)       Date:  2011-09-28       Impact factor: 3.575

Review 3.  Risk assessment for creatine monohydrate.

Authors:  Andrew Shao; John N Hathcock
Journal:  Regul Toxicol Pharmacol       Date:  2006-06-30       Impact factor: 3.271

4.  Inhibition of the mitochondrial permeability transition by creatine kinase substrates. Requirement for microcompartmentation.

Authors:  Max Dolder; Bernd Walzel; Oliver Speer; Uwe Schlattner; Theo Wallimann
Journal:  J Biol Chem       Date:  2003-03-05       Impact factor: 5.157

5.  Creatine phosphokinase and psychosis.

Authors:  D E Schweid; J S Steinberg; H S Sudak
Journal:  Arch Gen Psychiatry       Date:  1972-03

6.  Proton magnetic resonance spectroscopy of basal ganglia in chronic schizophrenia.

Authors:  T Fujimoto; T Nakano; T Takano; K Takeuchi; K Yamada; T Fukuzako; H Akimoto
Journal:  Biol Psychiatry       Date:  1996-07-01       Impact factor: 13.382

7.  Dietary supplementation with creatine monohydrate prevents corticosteroid-induced attenuation of growth in young rats.

Authors:  Brian D Roy; Jacqueline M Bourgeois; Douglas J Mahoney; Mark A Tarnopolsky
Journal:  Can J Physiol Pharmacol       Date:  2002-10       Impact factor: 2.273

8.  Creatine abnormalities in schizophrenia and bipolar disorder.

Authors:  Dost Ongür; Andrew P Prescot; J Eric Jensen; Bruce M Cohen; Perry F Renshaw
Journal:  Psychiatry Res       Date:  2009-02-23       Impact factor: 3.222

9.  Brain metabolic alterations in medication-free patients with bipolar disorder.

Authors:  Stephen R Dager; Seth D Friedman; Aimee Parow; Christina Demopulos; Andrew L Stoll; In Kyoon Lyoo; David L Dunner; Perry F Renshaw
Journal:  Arch Gen Psychiatry       Date:  2004-05

10.  X-linked creatine deficiency syndrome: a novel mutation in creatine transporter gene SLC6A8.

Authors:  Alberto Bizzi; Marianna Bugiani; Gajja S Salomons; Donald H Hunneman; Isabella Moroni; Margherita Estienne; Ugo Danesi; Cornelis Jakobs; Graziella Uziel
Journal:  Ann Neurol       Date:  2002-08       Impact factor: 10.422

View more
  40 in total

Review 1.  A mitochondrial bioenergetic basis of depression.

Authors:  N Jennifer Klinedinst; William T Regenold
Journal:  J Bioenerg Biomembr       Date:  2014-09-28       Impact factor: 2.945

2.  Chronic high-dose creatine has opposing effects on depression-related gene expression and behavior in intact and sex hormone-treated gonadectomized male and female rats.

Authors:  Patricia J Allen; Joseph F DeBold; Maribel Rios; Robin B Kanarek
Journal:  Pharmacol Biochem Behav       Date:  2015-01-03       Impact factor: 3.533

Review 3.  Realising the Potential of Urine and Saliva as Diagnostic Tools in Sport and Exercise Medicine.

Authors:  Angus Lindsay; Joseph T Costello
Journal:  Sports Med       Date:  2017-01       Impact factor: 11.136

4.  Betaine in the Brain: Characterization of Betaine Uptake, its Influence on Other Osmolytes and its Potential Role in Neuroprotection from Osmotic Stress.

Authors:  Leena S Knight; Quinn Piibe; Ian Lambie; Christopher Perkins; Paul H Yancey
Journal:  Neurochem Res       Date:  2017-09-16       Impact factor: 3.996

5.  Using MS-FINDER for identifying 19 natural products in the CASMI 2016 contest.

Authors:  Arpana Vaniya; Stephanie N Samra; Mine Palazoglu; Hiroshi Tsugawa; Oliver Fiehn
Journal:  Phytochem Lett       Date:  2016-12-09       Impact factor: 1.679

Review 6.  X-linked creatine transporter deficiency: clinical aspects and pathophysiology.

Authors:  Jiddeke M van de Kamp; Grazia M Mancini; Gajja S Salomons
Journal:  J Inherit Metab Dis       Date:  2014-05-01       Impact factor: 4.982

7.  Severe Hyperhomocysteinemia Decreases Creatine Kinase Activity and Causes Memory Impairment: Neuroprotective Role of Creatine.

Authors:  Janaína Kolling; Aline Longoni; Cassiana Siebert; Tiago Marcon Dos Santos; Eduardo Peil Marques; Jaqueline Carletti; Lenir Orlandi Pereira; Angela T S Wyse
Journal:  Neurotox Res       Date:  2017-06-27       Impact factor: 3.911

Review 8.  Targeting Mitochondrial Dysfunction for Bipolar Disorder.

Authors:  Maya Kuperberg; Sophie L A Greenebaum; Andrew A Nierenberg
Journal:  Curr Top Behav Neurosci       Date:  2021

9.  A spectroscopic approach toward depression diagnosis: local metabolism meets functional connectivity.

Authors:  Liliana Ramona Demenescu; Lejla Colic; Meng Li; Adam Safron; B Biswal; Coraline Danielle Metzger; Shijia Li; Martin Walter
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2016-08-25       Impact factor: 5.270

10.  Dose-response effects of oral guanidinoacetic acid on serum creatine, homocysteine and B vitamins levels.

Authors:  Sergej M Ostojic; Marko Stojanovic; Patrik Drid; Jay R Hoffman
Journal:  Eur J Nutr       Date:  2014-02-18       Impact factor: 5.614

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.